TGTX (US) share price forecast & AI signal — TG Therapeutics, Inc
Week of 2026-10-30 · Healthcare
Exact confidence, 1-week / 1-month / 3-month breakdown, plain-English AI write-up, bull-vs-bear debate, support & resistance.
Get 5 free tokens — no card Already a member? Open the full analysisWhat the model sees in TGTX
TG Therapeutics, Inc is a Healthcare stock listed on the US. For the week of 2026-10-30 the ACE machine-learning model rates it a SELL with low confidence, based on technical indicators and the stock's own historical patterns across three time horizons. The direction is updated every model run.
About TG Therapeutics, Inc
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Ublituximab IV, glycoengineered anti-CD20 mAb for the treatment of relapsing MS; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase...
Recent closes
| Date | Close |
|---|---|
| 2026-11-06 | $59.83 |
| 2026-11-05 | $57.98 |
| 2026-11-04 | $61.63 |
| 2026-11-03 | $60.75 |
| 2026-11-02 | $59.95 |
| 2026-10-30 | $61.18 |
| 2026-10-29 | $58.08 |
TGTX FAQ
Is TG Therapeutics, Inc (TGTX) a buy or sell this week?
The ACE Stock Bots machine-learning model rates TGTX a SELL for the week of 2026-10-30 with low confidence. The exact confidence and the 1-week, 1-month and 3-month breakdown are free with a signup (5 analysis tokens, no card).
What is the AI share price forecast for TGTX?
Every week the model scores TGTX across three horizons using technical indicators and the stock's own historical patterns. An AI then writes a plain-English summary with support and resistance levels, and a bull analyst and a bear analyst argue the case.
Is this financial advice?
No. ACE Stock Bots provides general information generated by software. It does not consider your objectives, financial situation or needs. Read the disclaimer and consider licensed advice before acting.
Other Healthcare stocks on the US
This week's top US picks · All US stocks
Signals are generated by software for general information only and are not a recommendation to buy or sell. See the disclaimer.